Abstract
Objective
To study the role of hyperhomocysteinemia in patients with intrauterine growth retardation.
Method
76 patients with intrauterine growth retardation were studied and compared with 50 controls which included pregnant patients without any pregnancy complications. Fasting Plasma homocysteine levels were measured and statistical analysis using tests of significance and logistic regression analysis was performed. Those in the study group were given homocysteine lowering agents for 6 wks and pregnancy outcome was studied.
Results
57.8 % women in the study group were found to have hyperhomocysteinemia. Logistic Regression analysis shows an OR of 2.45 in favor of occurrence of IUGR if homocysteine levels are raised which is statistically significant. Mean plasma homocysteine levels decreased after treatment for 6 wks but this decrease in the case of placebo group is marginal whereas the decrease in the homocysteine levels the treatment group. This implies that treatment has a definitive role in lowering of plasma homocysteine levels.
Conclusion
The present study shows that hyperhomocysteinemia is associated with IUGR and should be identified as a risk factor as correction favors pregnancy outcome.
References
Martinelli P, Grandone E, Colaizzo D, et al. Familial thrombophilia and the occurrence of fetal growth restriction. Haematologica. 2001;86:428–31.
Arias F, Romero R, Joist H, et al. Thrombophilia: a mechanism of disease in women with adverse pregnancy outcome and thrombotic lesions in the placenta. J Matern Fetal Med. 1998;7:277–86.
Many A, Screiber L, Rosner S, et al. Pathologic features of placenta in women with severe pregnancy complications and thrombophilia. Obstet Gynecol. 2001;98:1041–4.
Steegers-Theunissen RP, Van Iersel CA, Peer PG, et al. Hyperhomocysteinemia, pregnancy complications, and the timing of investigation. Obstet Gynecol. 2004;104:336–43.
Lindblad B, Zaman S, Malik A, et al. Vitamin B12, and homocysteine levels in South Asian Women with growth-retarded fetuses. Obstet Gynecol Surv. 2006;61:91–2.
Leeda M, Riyazi N, de vries JIP, et al. Effects of folic acid and vitamin B6 supplementation on women with hyperhomocysteinemia and a history of growth restriction or preeclampsia. Am J Obstet Gynecol. 1998;179:135–9.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Pandey, K., Dubay, P., Bhagoliwal, A. et al. Hyperhomocysteinemia as a Risk Factor for IUGR. J Obstet Gynecol India 62, 406–408 (2012). https://doi.org/10.1007/s13224-012-0287-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13224-012-0287-9